We are delighted to invite you to informal lunch sessions with renowned AD/PD™ faculty members.
| Peter St. George-Hyslop, Canada | MOVING FROM COMPUTATIONAL (GWAS, WGS AND MULTIOMICS) TO FUNCTIONAL BIOLOGY | |
| Charlotte Teunissen, Netherlands | BIOMARKER DEVELOPMENT ROADMAP – IT IS ALL ABOUT TEAMWORK | FULLY BOOKED |
| Pamela McLean, USA | BALANCING CAREER, FAMILY, AND LIFE | |
| Maria Grazia Spillantini, UK | TBA | |
| Tiago Outerio, Germany | THE SPECTRUM OF ALPHA-SYNUCLEIN SPECIES | |
| Dimitri Krainc, USA | CAREER OPPORTUNITIES IN ACADEMIA, BIOPHARMA AND VENTURE CAPITAL FIRMS | |
| Frank LaFerla, USA | BUILDING A FOUNDATION FOR EARLY CAREER SUCCESS | |
| Joanna Jankowsky, USA | MODELING DISEASE HETEROGENEITY IN THE LABORATORY | |
| Maria Ankarcrona, Sweden | FUTURE THERAPEUTIC APPROACHES FOR NEURODEGENERATIVE DISEASES- MULTITARGET COMPOUNDS OR A COCKTAIL OF DRUGS? | |
| Michael Schlossmacher, Sweden | FROM HYPOSMIA IN PARKINSON’S TO A TOOL FOR FASTER DIAGNOSIS AND TREATMENT |
| Kristine Freude, Denmark | SEX DIFFERENCES IN ALZHEIMER’S DISEASE: REALITY, CELL SPECIFICITY, AND MODELING CHALLENGES | |
| Angela Genge, Canada | POTENTIAL DRUG TARGET IN ALS DRUG DEVELOPMENT | |
| Philip Scheltens, The Netherlands | USE OF BIOMARKERS IN THE MEMORY CLINIC | |
| Donna Wilcock, USA | ACHIEVING WORK-LIFE INTEGRATION IN ACADEMIC RESEARCH | |
| Cheryl Wellington, Canada | VASCULAR CONTRIBUTIONS TO COGNITIVE IMPAIRMENT AND DEMENTIA | |
| Bart De Strooper, Belgium | SCIENCE, SERENDIPITY, AND CAREER JOURNEYS: AN OPEN CONVERSATION | |
| Lutz Frolich, Germany | PROSPECTS AND LIMITATIONS OF ANTI-AMYLOID TREATMENT | |
| Agneta Nordberg, Sweden | HOW TO WRITE A WINNING GRANT APPLICATION | FULLY BOOKED |
| Sam Sisodia, USA | HOW GENETICS INFORMS US ABOUT IMMUNE CELLS, THE MICROBIOME AND PATHOPHYSIOLOGY OF AD | |
| Takeshi Iwatsubo, Japan | FROM AD PATHOPHYSIOLOGY TO CLINICAL IMPLEMENTATION OF DISEASE-MODIFYING THERAPIES |
| Taylor Schmitz, Canada | MOVING TO ANOTHER COUNTRY FOR YOUR GRADUATE AND POSTGRADUATE RESEARCH: MAXIMIZING PROS AND MINIMIZING CONS | |
| Frank Longo, USA | A JOURNEY OF EXECUTING TRANSLATIONAL RESEARCH IN NEURODEGENERATIVE DISEASE – FROM NOVEL CONCEPT TO CLINICAL TRIALS | |
| Henne Holstege, The Netherlands | WHAT CAN WE LEARN FROM CENTENARIANS | |
| Robert Vassar, USA | THERAPEUTIC STRATEGIES TO PREVENT ALZHEIMER’S DISEASE | |
| Rhoda Au, USA | THE MYTH VERSUS THE REALITY OF DIGITAL BIOMARKERS | |
| Lea Grinberg, USA | SPONSORSHIP > MENTORSHIP: BREAKING IN AS A WOMAN SCIENTIST FROM THE GLOBAL SOUTH (AND DODGING THE “TOO-GOOD-TO-BE-TRUE” ALLURES) | |
| Michael Heneka, Luxemburg | NEUROINFLAMMATION | |
| Tim Bartels, UK | TRANSPARENCY AND CONTROVERSY: ADVANCING SCIENCE WITH INTEGRITY | |
| Kenneth Marek, USA | PARKINSON DISEASE PREVENTION |
| Klaus Gerwert, Germany | STRUCTURE BIOMARKER FOR PARKINSON AND ALZHEIMER RISK | |
| Claudio A. Cuello, Canada | SHOULD WE FOCUS ON TREATING ALZHEIMER’S DISEASE AT PRECLINICAL STAGES? | |
| David Holtzman, USA | MENTORING ADVICE FOR STUDENTS AND POST-DOCS | |
| Stuart A. Lipton, USA | THE INTERFACE OF GENOMICS AND PROTEOMICS IN NEURODEGENERATIVE DISORDERS | |
| Fabrizio Stocchi, Italy | ACTUAL AND FUTURE TREATMENT FOR PD | |
| Daniel Ferreira Padilla, Sweden | LET´S TALK ALL ABOUT DEMENTIA WITH LEWY BODIES | |
| Ornit Chiba-Falek, USA | LEVERAGING OMICS DISCOVERIES TO INCREASE PRECISION IN DRUG DEVELOPMENT FOR NEURODEGENERATIVE DISEASES | |
| Malu Tansey, USA | TARGETING INFLAMMATION AND IMMUNE DYSFUNCTION TO REDUCE RISK AND PROGRESSION OF NEURODEGENERATIVE DISEASES | |
| Bradley Boeve, USA | KEY PEARLS ON MENTORING AND BEING MENTORED | |
| Virginia Lee, USA | TBA |
You can book your Meet the Professor lunch session when registering for the Conference. If you wish to add Meet the Professor lunch session to your existing registration, please contact us at reg_adpd26@kenes.com
